Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Actelion
Actelion
Actelion sees Uptravi price of $160,000-170,000/patient
Yahoo/Reuters
Tue, 01/5/16 - 02:47 pm
Actelion
Uptravi
PAH
pulmonary arterial hypertension
Actelion says selexipag to enter U.S. market in January
Yahoo/Reuters
Tue, 12/22/15 - 10:56 am
Actelion
selexipag
Uptravi
PAH
pulmonary arterial hypertension
Actelion: We're interested in ZS Pharma, but not dependent on M&A
BioPharma Dive
Thu, 10/22/15 - 09:48 am
Actelion
ZS Pharma
M&A
With Opsumit launch rolling, Actelion doesn't 'need' M&A: CEO
Fierce Pharma
Tue, 10/20/15 - 09:53 pm
Actelion
Opsumit
M&A
PAH
pulmonary arterial hypertension
Actelion CFO says biotech could make acquisitions exceeding $2.5 bln
Yahoo/Reuters
Tue, 10/20/15 - 09:46 am
Actelion
M&A
Actelion raises 2015 earnings forecast after strong drug sales
Yahoo/Reuters
Tue, 10/20/15 - 09:45 am
Actelion
earnings
Actelion and ZS Pharma confirm acquisition talks
Marketwatch
Fri, 09/11/15 - 09:52 am
Actelion
ZS Pharma
Actelion's Opsumit growth heralds smooth switch off aging Tracleer
Fierce Pharma
Tue, 07/21/15 - 10:34 am
Actelion
Opsumit
Tracleer
PAH
pulmonary arterial hypertension
Actelion creates €30M vax startup, Immunocore expands Lilly deal, Cell Therapy seeks PhIII ally
Fierce Biotech
Thu, 07/2/15 - 11:12 am
Immunocore
Actelion
vaccines
Eli Lilly
Cell Therapy Group
The latest Shire buyout rumor: An $18.9B bid for Actelion
Fierce Biotech
Mon, 06/8/15 - 11:17 am
Shire
M&A
Actelion
Surging Actelion is on the hunt for buyouts amid 'M&A frenzy'
Fierce Biotech
Tue, 04/21/15 - 09:34 am
Actelion
M&A
Actelion launches Phase III MS test for ponesimod
Fierce Biotech
Thu, 04/16/15 - 12:31 pm
Actelion
MS
multiple sclerosis
ponesimod
Deep dive into Actelion's Uptravi data calms investors as FDA decision date nears
Fierce Biotech
Wed, 03/18/15 - 11:08 am
Actelion
Uptravi
PAH
pulmonary arterial hypertension
The top 10 patent losses of 2015
Fierce Pharma
Fri, 12/19/14 - 08:35 am
patents
Lantus
Abilify
Copaxone
Neulasta
Tracleer
Namenda
Avodart
Jalyn
Zyvox
Androgel
Synagis
Sanofi
Bristol-Myers Squibb
Otsuka
Teva Pharmaceutical
Amgen
Actelion
Actavis
GSK
Pfizer
AbbVie
AstraZeneca
Actelion Reports Strong Q3 Results, Says It Has Not Received Any Acquisition Offers From US Pharma Giants
Bidness Etc.
Tue, 10/21/14 - 09:22 am
Actelion
earnings
Actelion Says U.S. Tax-Inversion Limits Good for Industry
Bloomberg
Tue, 10/21/14 - 08:05 am
Actelion
tax inversions
M&A
Actelion Raises Full-Year Profit Forecast on Opsumit
Bloomberg
Tue, 07/22/14 - 08:58 am
Actelion
Opsumit
Tracleer
earnings
Perrigo, Actelion Tax Targets Abroad for U.S. Drugmakers
Bloomberg
Mon, 07/21/14 - 09:14 am
Perrigo Company
Actelion
Smith & Nephew
M&A
tax inversions
InterMune's A Strong Buy As Esbriet Finally Has The Data Physicians, Patients, And FDA Have Longed For
Seeking Alpha
Sun, 06/15/14 - 06:31 pm
InterMune
Esbriet
Actelion
Gilead Sciences
Actelion May Raise Forecast After First-Quarter Earnings
Bloomberg
Thu, 04/17/14 - 08:03 am
Actelion
earnings
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
next ›
last »